Pavan Kumar Dhanyamraju
7PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Aug 26, 2023
Nanomedicine Strategies for Targeting Tumor Stroma.Mei-Chi Su, Susheel Kumar Nethi, Pavan Kumar Dhanyamraju
|May 18, 2022
Drug-Tolerant Persister Cells in Cancer Therapy Resistance.Pavan Kumar Dhanyamraju, Todd D Schell, Shantu Amin
|Apr 19, 2022
Targeting WEE1/AKT Restores p53-Dependent Natural Killer-Cell Activation to Induce Immune Checkpoint Blockade Responses in "Cold" Melanoma.Saketh S Dinavahi, Yu-Chi Chen, Kishore Punnath
|Apr 12, 2022
Targeting Protein Translation in Melanoma by Inhibiting EEF-2 Kinase Regulates Cholesterol Metabolism though SREBP2 to Inhibit Tumour Development.Saketh S Dinavahi, Yu-Chi Chen, Raghavendra Gowda
|Apr 03, 2021
Mechanistic Basis for In Vivo Therapeutic Efficacy of CK2 Inhibitor CX-4945 in Acute Myeloid Leukemia.Morgann Klink, Mohammad Atiqur Rahman, Chunhua Song
|Nov 07, 2020
Medulloblastoma: "Onset of the molecular era".Pavan Kumar Dhanyamraju, Trupti N Patel, Sinisa Dovat
Pageof 2
Frequent Collaborators
1 joint publications
Arthur Berg
1 joint publications
Momeneh Foroutan
1 joint publications
Nicholas D Huntington
1 joint publications
Todd D Schell
1 joint publications
Jonathon L Payne
1 joint publications
Chunhua Song
1 joint publications
Yevgeniya Bamme
1 joint publications
Morgann Klink
1 joint publications
Melanie Ehudin
1 joint publications
Chandrika Gowda
